Reuters logo
BRIEF-Senhwa Biosciences gets Orphan Drug Designation from US FDA for CX-4945
January 4, 2017 / 6:20 AM / a year ago

BRIEF-Senhwa Biosciences gets Orphan Drug Designation from US FDA for CX-4945

Jan 4 (Reuters) - Senhwa Biosciences Inc :

* Says co gets Orphan Drug Designation from US FDA for its new anticarcinogen CX-4945

Source text in Chinese: goo.gl/ffGtEJ

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below